Pharma Mirror

MAY 10, 2021

FarmaTrust, the UK-based global medical supply chain data management provider – has warned that the UK is heading very rapidly down the wrong direction with vaccine passports. This is particularly important as the public needs comfort in respect of certification or vaccination apps, and concerns on access to individual’s health data.

Vaccines 52

Vaccines 52

Pharma Mirror

SEPTEMBER 11, 2022

Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Mirror

AUGUST 19, 2020

has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. The post Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology appeared first on Pharma Mirror Magazine.

Vaccines 52

Vaccines 52

Pharma Mirror

AUGUST 28, 2021

ADELAIDE- Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on “Non-clinical and clinical pathways for rapid vaccine development in Australia”, in a webinar hosted by Endpoints News Editor Arsalan Arif.

Vaccines 52

Vaccines 52

Pharma Mirror

SEPTEMBER 30, 2021

SINGAPORE; The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid.

Vaccines 52

Vaccines 52

Pharma Mirror

MAY 23, 2023

QS-21 is used in several innovative vaccines against diseases such as shingles, malaria and RSV, plus promising new vaccine and immunotherapy treatments such as cancer. BSI) partner to fast-track sustainable vaccine adjuvant QS-21 production appeared first on Pharma Mirror Magazine.

Vaccines 52

Vaccines 52

pharmaphorum

JANUARY 27, 2023

For vaccines that target infectious diseases, as Pragya Khurana and Dr Richard Pitman of ICON explain, cost-effectiveness research can power evidence generation and decision-making that helps keep people safe. Cost-effectiveness modelling is a powerful tool in understanding the value health interventions can bring to populations.

Vaccines 52

Vaccines 52

Pharma Mirror

OCTOBER 22, 2021

Considerations for Immuno-oncology and Vaccine Studies and the Bioanalytical Tools used” in partnership with Outsourcing Clinical Trials (OCT). PGCM) said: “Choosing the right bioanalytical platform for your immunology or vaccines clinical trial is critical to data collection. Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D,

Vaccines 52

Vaccines 52

Pharma Mirror

FEBRUARY 19, 2022

Although COVID-19 vaccine booster shots have been administered across the globe since 3Q2021, vaccine efficacy is shown to vary among vaccine products, and it is crucial.

Vaccines 52

Vaccines 52

pharmaphorum

JANUARY 20, 2023

For millions of people around the world living with infectious disease and cancer, the arrival of a new prophylactic or therapeutic vaccine on the market can be life changing. Commercialising a vaccine, even one that targets an unmet need, is a challenging task for companies.

Vaccines 52

Vaccines 52

Pharma Mirror

SEPTEMBER 2, 2020

The post Jacobson Pharma Collaborates with Fosun Pharma Group to Supply Potentially 10 Million Doses of BioNTech SE’s COVID-19 Vaccine Candidate in Hong Kong and Macau appeared first on Pharma Mirror Magazine. a wholly-owned subsidiary of Shanghai.

Vaccines 52

Vaccines 52

Pharma Mirror

FEBRUARY 18, 2021

A novel approach for ensuring the virtually unlimited production of QS-21, the ‘Gold Standard’ adjuvant for improving vaccine efficacy, will be the subject of an upcoming presentation at the BIO CEO & Investor Digital Conference, starting February 16.

Immunization 52

Immunization Immunity Vaccines 52

pharmaphorum

MARCH 26, 2021

As chief operating officer, Mullane has supported rapid expansion of the business as it branches into new geographies and business areas including the cell therapy market. • Read the full article in pharmaphorum’s Deep Dive digital magazine.

Vaccines 40

Vaccines 40

Express Pharma

MAY 14, 2025

The city accounts for nearly one-third of the countrys pharmaceutical production, one-fifth of its pharmaceutical exports, and one-third of global vaccine output. The report highlights Hyderabad as one of the key contributors and largest life sciences manufacturing and R&D cluster, undertaking research, training, and manufacturing.

Pharmaceutical Companies 66

Pharmaceutical Companies Pharmaceutical Companies Vaccines 66

Pharmaceutical Technology

JUNE 6, 2023

With two historic FDA approvals for RSV vaccines in the last two months, this issue’s lead interview addresses the pertinent question of access— how to ensure eligible individuals across the world get this vaccine.

Vaccines 52

Vaccines Communication 52

Pharma Mirror

APRIL 24, 2022

and NEC Corporation, today announced the execution of a strategic research collaboration agreement for the development of a novel hepatitis B therapeutic vaccine. The post Shionogi and NEC Enter into Strategic Research Collaboration for Novel Hepatitis B Therapeutic Vaccine appeared first on Pharma Mirror Magazine.

Vaccines 52

Vaccines 52

pharmaphorum

JANUARY 15, 2021

Now, speaking to him as the first vaccines are deployed in the UK, he highlights the importance of GSK’s employees and culture to the future of the company post-COVID. George Underwood is pharmaphorum’s Deep Dive magazine editor, leading the content for the bi-monthly magazine. About the author.

Vaccines 105

Vaccines Drug Development 105

STAT

APRIL 11, 2025

Yesterday, STAT won a National Magazine Award for General Excellence. Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.    Sign up here. Good morning, Jason Mast here filling in for Rose.

Vaccines 321

Vaccines Documentation 321

Pharmaceutical Technology

MARCH 1, 2023

Don’t miss an in-depth feature looking at the latest trends in decentralised clinical trials , and the story behind the development of Alzheimer’s disease vaccines. The post Magazine: ‘Right shoring’ API production in Europe appeared first on Pharmaceutical Technology.

Diabetes 52

Diabetes Vaccines 52

pharmaphorum

APRIL 30, 2021

Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks. It’s fair to say this is the most interesting time ever for market access.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

pharmaphorum

APRIL 7, 2021

It has brought a lot of good things working together and networking has led to unbelievable successes,” he added, noting the rapid development of vaccines by companies such as Pfizer/BioNTech, Moderna and AstraZeneca/Oxford University. Richard also contributes to pharmaphorum’s digital magazine, DeepDive.

Chemotherapy 91

Chemotherapy Hospitals Vaccines 91

Pharmaceutical Technology

MAY 1, 2023

The successful launch of mRNA vaccines during the Covid-19 pandemic has not only spurred mRNA-related research across interdisciplinary groups, but also further validated the use of lipid nanoparticles as delivery approaches.

Vaccines 52

Vaccines 52

Digital Pharmacist

DECEMBER 15, 2022

CVS MinuteClinics provide lab testing, clinical services, COVID-19 testing, and vaccination with or without an appointment. However, vaccination is the most frequently conducted service in community pharmacies, therefore, every community pharmacy should possess vaccines in stock and prepare their pharmacists not to miss sales opportunities.

Community Pharmacies 98

Community Pharmacies Medication Therapy Management (MTM) Pharmacy Management Pharmacy Technician 98

The Happy PharmD

AUGUST 3, 2022

Currently, she has a quarterly column with a magazine and takes up freelance gigs. . Warda graduated from pharmacy school in 2019 and has worked in retail while contributing her quota to the fight against COVID-19 through vaccination. In Milena’s case, she is in academia but wanted to do something extra with her skills.

Vaccines 52

Vaccines 52

pharmaphorum

APRIL 5, 2022

And the search for a COVID-19 vaccine opened the industry’s eyes to the idea that innovation could happen quickly, and their processes needn’t be sacrosanct. The risk equation changed for things like decentralised clinical trials, with companies that lacked the capacity for these trials falling behind.

Vaccines 52

Vaccines 52

pharmaphorum

DECEMBER 1, 2021

UK life sciences are buoyant with the success of the COVID-19 vaccine programme and a stream of innovation and investment marking it out for a starring role in the UK’s economic future. Bruntwood SciTech is the UK’s leading property provider dedicated to driving the growth of the science and technology sector.

Vaccines 52

Vaccines 52

Pharma Mirror

JANUARY 23, 2023

This webinar focused on the need for a coordinated clinical trials enterprise, one that can quickly characterize emerging viral threats and evaluate the effectiveness of vaccines, therapeutics, and other countermeasures across a diversity of trial participants.

Vaccines 59

Vaccines 59

pharmaphorum

APRIL 12, 2022

Wherever you consider the medical industry, you will find several new technologies being used to make new medicines, vaccines, and fight illnesses. The purpose is to make our lifestyle better and healthier. The last two decades have been revolutionary for the healthcare industry.

Vaccines 52

Vaccines 52

pharmaphorum

DECEMBER 18, 2020

Even when the virus is tamed, and recent advances with vaccines are grounds for much optimism, the huge societal and healthcare changes that we’ve seen take place this year will undoubtedly have left their mark in all sorts of altered, and new, approaches. The post Patient journeys in the era of COVID-19 appeared first on.

Vaccines 52

Vaccines 52

PharmaShots

MARCH 9, 2023

She ranked 2nd on the “Most Powerful International Women” of Fortune Magazine 2019 edition Education: She holds a master’s degree in classics and modern languages from Oxford University Other Affiliations: Emma was appointed as Independent Director for Microsoft board in Dec’19. LinkedIn Total experience: 31 yrs.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

Pharma Mirror

JANUARY 26, 2023

Within the region, the Indian market shows impressive success, responsible for 80% of anti-retroviral drugs and 50% of the global supply of vaccines. The APAC market is The post <strong>APAC overview: trends, challenges, and possibilities for growth in the MarTech sector</strong> appeared first on Pharma Mirror Magazine.

Vaccines 52

Vaccines 52

Pharma Mirror

MARCH 31, 2022

Symbiosis Pharmaceutical Services Ltd (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile global manufacture of pharmaceuticals, vaccines and biopharmaceuticals including Advanced Therapeutical Medicinal Products (ATMPs), has announced the completion of a £1.3

Vaccines 52

Vaccines 52

Pharma Mirror

OCTOBER 28, 2021

The analysis foresees the use of automated cobots, AI, real-time release and rapid growth in new areas like mRNA vaccines, alongside the personalization of therapeutics (delivered at far larger scale). These new findings are released ahead of CPhI Worldwide (November 9-11, 2021), which is being held.

Vaccines 52

Vaccines 52

pharmaphorum

FEBRUARY 26, 2021

Big pharma might have dominated COVID headlines with its vaccine drive, but behind the scenes an army of SMEs has allowed the UK to respond swiftly to the pandemic. Culture changes – FUJIFILM Irvine Scientific’s COO on cell therapy, COVID vaccines and 50 years of the company. The landscape for UK SMEs post-COVID.

Vaccines 59

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Mirror

MAY 10, 2023

These systems also utilize refrigerant, which limits cooling to approximately -100°C and is known to The post Liquid Nitrogen Freezers Prove to be Game Changer for Pharma Industry appeared first on Pharma Mirror Magazine. Unfortunately, traditional mechanical freezers are limited in significant aspects.

Vaccines 52

Vaccines 52

Pharma Mirror

MARCH 29, 2022

NIEL, BELGIUM, eTheRNA Manufacturing, a specialist RNA process developer and manufacturing member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and early pre-clinical development of RNA-based therapeutics and vaccines.

Vaccines 52

Vaccines 52

Pharma Mirror

FEBRUARY 18, 2022

By Christopher Weikart, Chief Scientist, SiO2 Materials Science Even though drugs are meant to save lives, the primary packaging used for delivering drug therapies and vaccines may actually be putting us in danger. The post 7 Problems with Using Borosilicate Glass to Package Drugs appeared first on Pharma Mirror Magazine.

Packaging 52

Packaging Vaccines 52